TOC Commits to Uniform Racehorse Medication Program

TOC Commits to Uniform Racehorse Medication Program

Under the Mid-Atlantic Uniform Medication Program, furosemide (also known as Salix or Lasix) will be the only medication permitted to be administered on race day.

Photo: Anne M. Eberhardt/The Horse

Thoroughbred Owners of California (TOC) will join regulators from eight states in the mid-Atlantic and Northeast by committing to implement the Mid-Atlantic Uniform Medication Program beginning in January 2014, it was announced May 23.

According to a release, the agreement spearheaded by the Thoroughbred Horsemen's Association (THA), "represents the most dramatic change in medication regulation and testing in the last 50 years and could pave the way for national uniformity."

Rick Arthur, DVM, medical director of the California Horse Racing Board, said too often officials have played "gotcha" with owners and trainers, who had to worry they would be penalized for race-day residue from drugs that were legal and medically necessary when they were used.

"This is what horsemen have been clamoring for for years," Arthur said.

Arthur said the group's medication committee approved the regulatory language May 22. A full board review is expected in July.

Other participating states are Delaware, Maryland, Massachusetts, New York, New Jersey, Pennsylvania, Virginia, and West Virginia. The program includes a two-category drug classification system—controlled therapeutic medications and prohibited substances.

Furosemide (also known as Salix or Lasix) will be the only medication permitted to be administered on race day. Additionally, regulatory thresholds and withdrawal guidelines will be spelled out for 24 controlled therapeutic medications.

Testing laboratories of the participating states will perform uniform testing using the same state-of-the-art technology and detection levels. To ensure that the laboratories are working uniformly and to the highest standards, each will be committed to accreditation by the recently enacted Racing Medication and Testing Consortium code of standards for drug testing laboratories.

"We look forward to working through the process with the California Horse Racing Board and horsemen to begin this program on January 1," said TOC president Joe Morris. "It is vitally important to help bring together a national effort and uniformity when it comes to medication."

"Implementing the Mid-Atlantic Uniform Medication Program was an easy decision for the TOC since their regulations practically mirror what we've been doing for the past year," said Mark Dedomenico, MD, TOC medication chair.

TOC is the official organization serving Thoroughbred owners in the state. It represents owners' interests and rights in legislative, administrative, and business matters.

"Horsemen have been asking for this for years," said THA chairman Alan Foreman. "The time has come, and we are finally in a position to do it. Many horsemen race in more than one state and, in some instances, on the same day. We are extremely grateful to the TOC for their support of this very important program."

Originally published on

About the Author

The Blood-Horse Staff

The Blood-Horse is the leading weekly publication devoted to international Thoroughbred racing and breeding. Since 1916, the staff of The Blood-Horse has served the Thoroughbred community with the highest standards of journalistic excellence to provide comprehensive and timely editorial coverage and analysis.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from Learn More